- Home
- EHTH vs ANVS Comparison
EHTH vs ANVS Comparison
Compare EHTH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHTH
- ANVS
- Stock Information
- Founded
- EHTH 1997
- ANVS 2008
- Country
- EHTH United States
- ANVS United States
- Employees
- EHTH N/A
- ANVS N/A
- Industry
- EHTH Specialty Insurers
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- EHTH Finance
- ANVS Health Care
- Exchange
- EHTH Nasdaq
- ANVS Nasdaq
- Market Cap
- EHTH 105.1M
- ANVS 48.3M
- IPO Year
- EHTH 2006
- ANVS 2020
- Fundamental
- Price
- EHTH $3.85
- ANVS $2.32
- Analyst Decision
- EHTH Buy
- ANVS Strong Buy
- Analyst Count
- EHTH 4
- ANVS 4
- Target Price
- EHTH $8.50
- ANVS $17.33
- AVG Volume (30 Days)
- EHTH 268.4K
- ANVS 198.0K
- Earning Date
- EHTH 11-05-2025
- ANVS 11-07-2025
- Dividend Yield
- EHTH N/A
- ANVS N/A
- EPS Growth
- EHTH N/A
- ANVS N/A
- EPS
- EHTH N/A
- ANVS N/A
- Revenue
- EHTH $547,491,000.00
- ANVS N/A
- Revenue This Year
- EHTH $4.99
- ANVS N/A
- Revenue Next Year
- EHTH $3.41
- ANVS N/A
- P/E Ratio
- EHTH N/A
- ANVS N/A
- Revenue Growth
- EHTH 16.19
- ANVS N/A
- 52 Week Low
- EHTH $3.18
- ANVS $1.11
- 52 Week High
- EHTH $11.36
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- EHTH 49.68
- ANVS 43.70
- Support Level
- EHTH $3.82
- ANVS $2.26
- Resistance Level
- EHTH $4.09
- ANVS $2.51
- Average True Range (ATR)
- EHTH 0.20
- ANVS 0.11
- MACD
- EHTH -0.00
- ANVS 0.01
- Stochastic Oscillator
- EHTH 23.81
- ANVS 35.48
About EHTH eHealth Inc.
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.